Search Prime Grants

UH3CA233229

Cooperative Agreement

Overview

Grant Description
ACCISIS-CHICAGO
Awardee
Pennsylvania State University
Funding Goals
TO PROVIDE SUPPORT FOR INITIATIVES FUNDED UNDER THE 21ST CENTURY CURES ACT TO SUPPORT CANCER RESEARCH, SUCH AS THE DEVELOPMENT OF CANCER VACCINES, THE DEVELOPMENT OF MORE SENSITIVE DIAGNOSTIC TESTS FOR CANCER, IMMUNOTHERAPY AND THE DEVELOPMENT OF COMBINATION THERAPIES, AND RESEARCH THAT HAS THE POTENTIAL TO TRANSFORM THE SCIENTIFIC FIELD, THAT HAS INHERENTLY HIGHER RISK, AND THAT SEEKS TO ADDRESS MAJOR CHALLENGES RELATED TO CANCER.
Grant Program (CFDA)
93.353 - 21st Century Cures Act - Beau Biden Cancer Moonshot
Awarding / Funding Agency
National Cancer Institute (NCI) [HHS - NIH]
Place of Performance
Hershey, Pennsylvania 170332360 United States
Geographic Scope
Single Zip Code
Related Opportunity
Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) (PA-21-268)
Analysis Notes
Amendment Since initial award the End Date has been extended from 08/31/23 to 08/31/24 and the total obligations have increased 296% from $1,296,000 to $5,138,482.
Pennsylvania State University was awarded ACCISIS-Chicago Cooperative Agreement UH3CA233229 worth $5,138,482 from National Cancer Institute in September 2018 with work to be completed primarily in Hershey Pennsylvania United States. The grant has a duration of 6 years and was awarded through assistance program 93.353 21st Century Cures Act - Beau Biden Cancer Moonshot. The Cooperative Agreement was awarded through grant opportunity Change of Recipient Organization (Type 7 Parent Clinical Trial Optional).

Status
(Complete)

Last Modified 12/20/24

Period of Performance
9/21/18
Start Date
8/31/24
End Date
100% Complete

Funding Split
$5.1M
Federal Obligation
$0.0
Non-Federal Obligation
$5.1M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to UH3CA233229

Subgrant Awards

Disclosed subgrants for UH3CA233229

Transaction History

Modifications to UH3CA233229

Additional Detail

Award ID FAIN
UH3CA233229
SAI Number
UH3CA233229-954269322
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Other
Awarding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Funding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Awardee UEI
TNKGNDAWB445
Awardee CAGE
7W765
Performance District
PA-10
Senators
Robert Casey
John Fetterman

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) Health research and training Grants, subsidies, and contributions (41.0) $5,184,000 100%
Modified: 12/20/24